BLOOD IRRADIATION MARKET ANALYSIS

Market Challenges And Opportunities

Increasing global population vulnerable to various communicable and non-communicable diseases (NCD’s) such as cancer, chronic kidney disease, high blood pressure disease, stroke and cardiovascular diseases, which is expected to drive the global blood irradiation market growth.

Infections in the blood stream are diagnosed and irradiated by laser irradiation therapies. Increasing use of such therapies is driving manufacturers to develop innovative blood irradiation systems for improved health treatments, which is directly boosting the market growth.

However, regulatory policies regarding the medical systems and lack of skilled professionals in emerging economies are likely to hamper the market growth. For instance, The Center for Biologics Evaluation and Research (CBER) regulates the collection of blood and blood components used for transfusion, CBER develops and enforces quality standards, inspects blood establishments and monitors reports of errors, accidents and adverse clinical events.